LeonaBio, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-105.6M | $-96.9M | $-117.7M | $-95.6M | $-54.9M | $-20.0M | $-5.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $972.0K | $970.0K | $969.0K | $845.0K | $479.0K | $2.0K | $2.0K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $6.1M | $11.0M | $10.6M | $10.6M | $4.6M | $633.0K | $253.0K |
| Net Cash from Operating Activities | $-45.7M | $-97.2M | $-100.8M | $-72.5M | $-43.1M | $-24.1M | $-3.7M |
| Investing Activities | |||||||
| Capital Expenditures | — | $33.0K | $304.0K | $1.1M | $1.6M | $2.3M | — |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-15.9M | $54.8M | $95.1M | $57.7M | $-4.1M | $-210.1M | $1.5M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $82.5M | $194.0K | $493.0K | $654.0K | $97.1M | $292.8M | $946.0K |
| Net Change in Cash | $20.8M | $-42.1M | $-5.2M | $-14.2M | $49.9M | $58.6M | $-1.3M |
| Free Cash Flow | — | $-97.2M | $-101.1M | $-73.6M | $-44.7M | $-26.4M | — |